Pittsburgh biotech firm involved in development of potential COVID-19 treatment

30Apr

Pittsburgh biotech firm involved in development of potential COVID-19 treatment

Portfolio News
CytoAgents, a Pittsburgh biotech firm, and Quotient Sciences, are accelerating development of a COVID-19 treatment. The treatment would focus on what is called a “cytokine storm,” which is an excessive immune response that attacks the body. Read more >>

Share this post

Related Posts

20May

CleanFiber secures $14 million for Lackawanna expansion

A past 43North winner is expanding again after securing $14 million in debt financing. Five years after the company moved... read more
01Mar

Xylyx Bio launches new website to showcase growing portfolio of regenerative biotechnologies

Xylyx Bio, a New York-based regenerative medicine company leading the development of advanced biomaterials and biosystems, is proud to announce... read more
20Jan

Blind Woman Raising Money For High Tech Glasses

But last fall Laura tried eSight glasses. “It was incredible,” she says. Read more >> read more
21Jul

Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human Trials

Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, has been awarded a $1,700,000 Small Business Innovation Research... read more
21Oct

Gift of new technology allows legally blind university student see

A legally blind university student in Sault Ste. Marie was recently gifted a pair of high-tech goggles to help her... read more
08Jan

EcoSoul: Making a Difference

Noida-based D2C-first company EcoSoul sells eco-friendly home essentials. And it doesn’t use paper to make them…In just three years since... read more
26May

Companies up for achievement awards

Eleven companies will be honoured at the Nova Scotia Export Achievement Awards on June 12, including Spring Loaded Technology. Read... read more
24Sep

Poplar Grove student doesn’t mind standing out in a crowd if it means better learning

Ellie Leden sticks out in a second-grade classroom because of her headgear. She doesn’t mind. After all, she sees a lot... read more
26May

Legally blind Titusville woman uses high-tech camera goggles to see the world

Elledge, 66, who had polio as a child and is legally blind, suffers from optic atrophy. There is no effective... read more
09Dec

RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation

RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a 20-patient pilot... read more